Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：4
|
作者：
Rodriguez, Cesar A. [1 ]
Martin, Teresa [1 ]
Lozano, Rebeca [1 ]
Gomez, Amalia [1 ]
Cruz, Juan J. [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain
来源：
BREAST JOURNAL | 2017年 / 23卷 / 06期
关键词：
bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;
D O I：
10.1111/tbj.12913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [1] Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
    Mailliez, A.
    Baldini, C.
    Van, J. T.
    Servent, V.
    Mallet, Y.
    Bonneterre, J.
    BRITISH JOURNAL OF CANCER, 2010, 103 (06) : 772 - 775
  • [2] VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis
    dos Santos, Lucas Vieira
    Cruz, Marcelo Rocha
    Lopes, Gilberto de Lima
    da Silveira Nogueira Lima, Joao Paulo
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 481 - 489
  • [3] Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients
    Yu, Irene
    Chen, Leo
    Ruan, Jenny Y.
    Chang, Jennifer T.
    Cheung, Winson Y.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1199 - 1208
  • [4] Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
    A Mailliez
    C Baldini
    J T Van
    V Servent
    Y Mallet
    J Bonneterre
    British Journal of Cancer, 2010, 103 : 772 - 775
  • [5] A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer
    Petrelli, Fausto
    Cabiddu, Mary
    Barbara, Cecilia
    Barni, Sandro
    BREAST CANCER, 2011, 18 (03) : 226 - 230
  • [6] Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients
    Irene Yu
    Leo Chen
    Jenny Y. Ruan
    Jennifer T. Chang
    Winson Y. Cheung
    Supportive Care in Cancer, 2016, 24 : 1199 - 1208
  • [7] Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer
    Pentheroudakis, George
    Kotoula, Vassiliki
    Kouvatseas, George
    Charalambous, Elpida
    Dionysopoulos, Dimitrios
    Zagouri, Flora
    Koutras, Angelos
    Papazisis, Konstantinos
    Pectasides, Dimitrios
    Samantas, Epaminontas
    Dimopoulos, Meletios A.
    Papandreou, Christos N.
    Fountzilas, George
    CLINICAL BREAST CANCER, 2014, 14 (05) : 330 - 338
  • [8] Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer
    Feliu, Jaime
    Salud, Antonieta
    Safont, Maria J.
    Garcia-Giron, Carlos
    Aparicio, Jorge
    Losa, Ferran
    Bosch, Carlos
    Escudero, Pilar
    Casado, Enrique
    Jorge, Monica
    Bohn, Uriel
    Perez-Carrion, Ramon
    Carmona, Alberto
    Custodio, Ana B.
    Maurel, Joan
    PLOS ONE, 2015, 10 (01):
  • [9] Spontaneous Nasal Septal Perforation With Antiangiogenic Bevacizumab Therapy
    Burkart, Collin M.
    Grisel, Jedidiah J.
    Hom, David B.
    LARYNGOSCOPE, 2008, 118 (09) : 1539 - 1541
  • [10] VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis
    Lucas Vieira dos Santos
    Marcelo Rocha Cruz
    Gilberto de Lima Lopes
    Joao Paulo da Silveira Nogueira Lima
    Breast Cancer Research and Treatment, 2015, 151 : 481 - 489
12345